Potential Targeting Mechanisms for Bone-Directed Therapies

• Published in: International journal of molecular sciences Vol. 25; no. 15; p. 8339
• Main Authors: Celik, Betul, Leal, Andrés Felipe, Tomatsu, Shunji
• Format: Journal Article
• Language: English
• Published: Switzerland MDPI AG 01.08.2024
• Subjects: Achondroplasia; Animals; Bioavailability; Bone and Bones - metabolism; bone and cartilage development; Bone Development - drug effects; Bone Diseases - therapy; Bone marrow; bone targeting; Cartilage; Cellular signal transduction; Collagen; Drug delivery systems; Drug Delivery Systems - methods; Drugs; Enzymes; Genetic Therapy - methods; glycobiology; Hematopoietic stem cells; Heparan sulfate; Humans; Kinases; Ligands; Mediation; Osteoarthritis; Peptides; Physiology; Proteins; receptor mediation; Signal transduction; Transplantation; Vehicles; bone targeting; bone and cartilage development; glycobiology; receptor mediation
• ISSN: 1422-0067; 1661-6596; 1422-0067
• DOI: 10.3390/ijms25158339

Bone development is characterized by complex regulation mechanisms, including signal transduction and transcription factor-related pathways, glycobiological processes, cellular interactions, transportation mechanisms, and, importantly, chemical formation resulting from hydroxyapatite. Any abnormal regulation in the bone development processes causes skeletal system-related problems. To some extent, the avascularity of cartilage and bone makes drug delivery more challenging than that of soft tissues. Recent studies have implemented many novel bone-targeting approaches to overcome drawbacks. However, none of these strategies fully corrects skeletal dysfunction, particularly in growth plate-related ones. Although direct recombinant enzymes (e.g., Vimizim for Morquio, Cerezyme for Gaucher, Elaprase for Hunter, Mepsevii for Sly diseases) or hormone infusions (estrogen for osteoporosis and osteoarthritis), traditional gene delivery (e.g., direct infusion of viral or non-viral vectors with no modifications on capsid, envelope, or nanoparticles), and cell therapy strategies (healthy bone marrow or hematopoietic stem cell transplantation) partially improve bone lesions, novel delivery methods must be addressed regarding target specificity, less immunogenicity, and duration in circulation. In addition to improvements in bone delivery, potential regulation of bone development mechanisms involving receptor-regulated pathways has also been utilized. Targeted drug delivery using organic and inorganic compounds is a promising approach in mostly preclinical settings and future clinical translation. This review comprehensively summarizes the current bone-targeting strategies based on bone structure and remodeling concepts while emphasizing potential approaches for future bone-targeting systems.